Corrigendum: Estrogen receptor β inhibits estradiol-induced proliferation and migration of MCF-7 cells through regulation of mitofusin 2 (International Journal of Oncology (2013) 42 (1993-2000) DOI: 10.3892/ijo.2013.1903);Estrogen receptor β inhibits estradiol-induced proliferation and migration of MCF-7 cells through regulation of mitofusin 2

International Journal of Oncology

Volumn 42, Issue 6, 2013, Pages 1993-2000

  Ma, Li ^a,b   Liu, Yueping ^b   Geng, Cuizhi ^b   Qi, Xiaowei ^a   Jiang, Jun ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Estrogen receptor ; Migration; Mitofusin 2; Proliferation

Indexed keywords

CYCLINE; ESTRADIOL; ESTROGEN RECEPTOR BETA; MITOFUSIN 2;

ARTICLE; CANCER INHIBITION; CELL ASSAY; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; EXPRESSION VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MONOLAYER CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING;

EID: 84876512158     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2016.3695     Document Type: Erratum

References (40)

1. MacGregor JI and Jordan VC: Basic guide to the mechanisms of antiestrogen action. Pharmacol Rev 50: 151-196, 1998. (Pubitemid 28305723)
2. Sommer S and Fuqua SA: Estrogen receptor and breast cancer. Semin Cancer Biol 11: 339-352, 2001. (Pubitemid 33016029)
3. Green S, Walter P, Greene G, et al: Cloning of the human oestrogen receptor cDNA. J Steroid Biochem 24: 77-83, 1986. (Pubitemid 16047760)
4. Kuiper GG, Enmark E, Pelto-Huikko M, et al: Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93: 5925-5930, 1996. (Pubitemid 26190778)
5. Katzenellenbogen BS, Montano MM, Ediger TR, et al: Estrogen receptors: selective ligands, partners, and distinctive pharmacology. Recent Prog Horm Res 55: 163-193, 2000.
6. Nilsson S, Makela S, Treuter E, et al: Mechanisms of estrogen action. Physiol Rev 81: 1535-1565, 2001. (Pubitemid 32951806)
7. Speirs V, Carder PJ, Lane S, et al: Oestrogen receptor β: what it means for patients with breast cancer. Lancet Oncol 5: 174-181, 2004 (Pubitemid 38262850)
8. Dahlman-Wright K, Cavailles V, Fuqua SA, et al: International Union of Pharmacology. LXIV. Estrogen receptors. Pharmacol Rev 58: 773-781, 2006. (Pubitemid 44833745)
9. Harris HA: Estrogen receptor-β: recent lessons from in vivo studies. Mol Endocrinol 21: 1-13, 2007 (Pubitemid 46041687)
10. Chen KH, Guo X, Ma D, et al: Dysregulation of HSG triggers vascular proliferative disorders. Nat Cell Biol 6: 872-883, 2004 (Pubitemid 39207252)
11. Neuspiel M, Zunino R, Gangaraju S, et al: Activated mitofusin 2 signals mitochondrial fusion, interferes with Bax activation, and reduces susceptibility to radical induced depolarization. J Biol Chem 280: 25060-25070, 2005. (Pubitemid 40934597)
12. Santel A, Frank S, Gaume B, et al: Mitofusin-1 protein is a generally expressed mediator of mitochondrial fusion in mammalian cells. J Cell Sci 116: 2763-2774, 2003. (Pubitemid 36857227)
13. Sugioka R, Shimizu S and Tsujimoto Y: Fzo1, a protein involved in mitochondrial fusion, inhibits apoptosis. J Biol Chem 279: 52726-52734, 2004 (Pubitemid 39656648)
14. DeNardo DG, Kim HT, Hilsenbeck S, et al: Global gene expression analysis of estrogen receptor transcription factor cross talk in breast cancer: identifcation of estrogen-induced/activator protein-1-dependent genes. Molecular Endocrinology 19: 362-378, 2005. (Pubitemid 40223461)
15. Ma L, Liu YP, Geng CZ, et al: Low-dose epirubicin inhibits ezrin-mediated metastatic behavior of breast cancer cells. Tumori 97: 400-405, 2011.
16. Ström A, Hartman J, Foster JS, et al: Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci USA 101: 1566-1571, 2004 (Pubitemid 38236167)
17. Secreto FJ, Monroe DG, Dutta S, et al: Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells. J Cell Biochem 101: 1125-1147, 2007 (Pubitemid 47253715)
18. Chen L, Qiu J, Yang C, et al: Identifcation of a novel estrogen receptor beta1 binding partner, inhibitor of differentiation-1, and role of ERbeta1 in human breast cancer cells. Cancer Lett 278: 210-219, 2009
19. Jensen EV, Cheng G, Palmieri C, et al: Estrogen receptors and proliferation markers in primary and recurrent breast cancer. Proc Natl Acad Sci USA 44, 2001.
20. Speirs V, Malone C, Walton DS, et al: Increased expression of estrogen receptor β mRNA in tamoxifen-resistant breast cancer patients. Cancer Res 59: 5421-5424, 1999 (Pubitemid 29526448)
21. Kushner PJ, Agard DA, Greene GL, et al: Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 74: 311-317, 2000. (Pubitemid 32126243)
22. Wang W, Dong L, Saville B, et al: Transcriptional activation of E2F1 gene expression by 17β-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions. Mol Endocrinol 13: 1373-1387, 1999 (Pubitemid 30645293)
23. Safe S: Transcriptional activation of genes by 17β-estradiol through estrogen receptor-Sp1 interactions. Vitam Horm 62: 231-252, 2001. (Pubitemid 33805706)
24. Ru Lee W, Chen CC, Liu S, et al: 17 beta-estradiol (E2) induces cdc25A gene expression in breast cancer cells by genomic and non-genomic pathways. J Cell Biochem 99: 209-220, 2006. (Pubitemid 44297965)
25. Yoshioka H, Hiromori Y, Aoki A, et al: Possible aryl hydrocarbon receptor-independent pathway of 2, 3, 7, 8-tetra-chlorodibenzo-p-dioxin-induced antiproliferative response in human breast cancer cells. Toxicol Lett 211: 257-265, 2012.
26. Singh KP, Treas J, Tyagi T, et al: DNA demethylation by 5-aza-2-deoxycytidine treatment abrogates 17 beta-estradiol-induced cell growth and restores expression of DNA repair genes in human breast cancer cells. Cancer Lett 316: 62-69, 2012.
27. Wang W, Zhou D, Wei J, et al: Hepatitis B virus X protein inhibits p53-mediated upregulation of mitofusin-2 in hepatocellular carcinoma cells. Biochem Biophys Res Commun 421: 355-360, 2012.
28. Jin B, Fu G, Pan H, et al: Anti-tumour effcacy of mitofusin-2 in urinary bladder carcinoma. Med Oncol 28 (Suppl 1): S373-S380, 2011.
29. Rehman J, Zhang HJ, Toth PT, et al: Inhibition of mitochondrial fssion prevents cell cycle progression in lung cancer. FASEB J 26: 2175-2186, 2012.
30. Dotzlaw H, Leygue E, Watson PH, et al: Expression of estrogen receptor-β in human breast tumors. J Clin Endocrinol Metab 82: 2371-2374, 1997 (Pubitemid 27287615)
31. Fuqua SA, Schiff R, Parra I, et al: Estrogen receptor β protein in human breast cancer: correlation with clinical tumor parameters. Cancer Res 63: 2434-2439, 2003. (Pubitemid 36605180)
32. Pettersson K, Delaunay F and Gustafsson JA: Estrogen receptor β acts as a dominant regulator of estrogen signaling. Oncogene 19: 4970-4978, 2000.
33. Matthews J, Wihlen B, Tujague M, et al: Estrogen receptor (ER) β modulates ER α-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters. Mol Endocrinol 20: 534-543, 2006. (Pubitemid 43292585)
34. Chang EC, Frasor J, Komm B, et al: Impact of estrogen receptor β on gene networks regulated by estrogen receptor α in breast cancer cells. Endocrinology 147: 4831-4842, 2006. (Pubitemid 44402189)
35. Lin CY, Strom A, Li Kong S, et al: Inhibitory effects of estrogen receptor beta on specifc hormone-responsive gene expression and association with disease outcome in primary breast cancer. Breast Cancer Res 9: R25, 2007
36. Williams C, Edvardsson K, Lewandowski SA, et al: A genome-wide study of repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells. Oncogene 27: 1019-1032, 2008. (Pubitemid 351225390)
37. Paruthiyil S, Parmar H, Kerekatte V, et al: Estrogen receptor β inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res 64: 423-428, 2004 (Pubitemid 38114127)
38. Behrens D, Gill JH and Fichtner I: Loss of tumourigenicity of stably ER β-transfected MCF-7 breast cancer cells. Mol Cell Endocrinol 27419-29, 2007
39. Nadal-Serrano M, Sastre-Serra J, Pons DG, et al: The ERalpha/ERbeta ratio determines oxidative stress in breast cancer cell lines in response to 17beta-estradiol. J Cell Biochem 113: 3178-3185, 2012.
40. Sastre-Serra J, Nadal-Serrano M, Pons DG, et al: The effects of 17β-estradiol on mitochondrial biogenesis and function in breast cancer cell lines are dependent on the ERα/ERβ ratio. Cell Physiol Biochem 29: 261-268, 2012.